Extracellular Vesicles From Chylomicron-Treated Endothelial Cells Drive Macrophage Inflammation
Authors:
- Dimitris NasiasDNDimitris Nasias
- Ashley MooringAMAshley Mooring
- Munichandra Babu TirumalasettyMTMunichandra Babu Tirumalasetty
- Nada A. AbumradNANada A. Abumrad
- Yang WangYWYang Wang
- Qing Robert MiaoQMQing Robert Miao
- E. Douglas LewandowskiELE. Douglas Lewandowski
- José O. AlemánJAJosé O. Alemán
- Ira J. GoldbergIGIra J. Goldberg
- 1 December 2025
- journal article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 45 (12) , 2179-2195
Abstract
BACKGROUND: Movement of circulating lipids into tissues and arteries requires transfer across the endothelial cell (EC) barrier. This process allows the heart to obtain fatty acids, its chief source of energy, and apoB-containing lipoproteins to cross the arterial endothelial barrier, leading to cholesterol accumulation in the subendothelial space. Multiple studies have established elevated postprandial TRLs (triglyceride-rich lipoproteins) as an independent risk factor for cardiovascular disease. We explored how chylomicrons affect ECs and transfer their fatty acids across the EC barrier. METHODS: We had reported that media from chylomicron-treated ECs lead to lipid droplet formation in macrophages. To determine the responsible component of this media, we assessed whether removing the extracellular vesicles (EVs) would obviate this effect. EVs from control and treated cells were then characterized by protein, lipid, and microRNA content. We also studied the EV-induced transcription changes in macrophages and ECs and whether knockdown of SR-BI (scavenger receptor-BI) altered these responses. In addition, using chylomicrons labeled with [ 13 C]oleate, we studied the uptake and release of this labeled by ECs. RESULTS: Chylomicron treatment of ECs led to an inflammatory response that included production of EVs that drove macrophage lipid droplet accumulation. The EVs contained little free fatty acids and triglycerides, but abundant phospholipids and diacylglycerols. In concert with this, [ 13 ]C labeled chylomicron triglycerides exited ECs primarily in phospholipids. EVs from chylomicron-treated versus untreated ECs were larger, more abundant, and contained specific microRNAs. Treatment of macrophages and naive ECs with media from chylomicron-treated ECs increased expression of inflammatory genes. CONCLUSIONS: EC chylomicron metabolism produces EVs that increase macrophage inflammation and create LDs. Media containing these EVs also increases EC inflammation, illustrating an autocrine inflammatory process. Fatty acids within chylomicron triglycerides are converted to phospholipids within EVs. Thus, EC uptake of chylomicrons constitutes an important pathway for vascular inflammation and tissue lipid acquisition.Keywords
All Related Versions
This publication has 65 references indexed in Scilit:
- Apolipoprotein B vs Low-Density Lipoprotein Cholesterol and Non–High-Density Lipoprotein Cholesterol as the Primary Measure of Apolipoprotein B Lipoprotein-Related RiskJAMA Cardiology, 2022
- Endothelial cell apoptosis and the role of endothelial cell-derived extracellular vesicles in the progression of atherosclerosisCellular and Molecular Life Sciences, 2018
- An Endothelial-to-Adipocyte Extracellular Vesicle Axis Governed by Metabolic StateCell, 2018
- Diabetes DyslipidemiaDiabetes Therapy, 2016
- New insights into the pathophysiology of dyslipidemia in type 2 diabetesAtherosclerosis, 2015
- Lipid droplet biogenesisCurrent Opinion in Cell Biology, 2014
- Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and WomenJAMA, 2007
- Postprandial lipemia and cardiovascular diseaseCurrent Atherosclerosis Reports, 2003
- Diabetic dyslipidaemia: from basic research to clinical practice*Diabetologia, 2003
- One technique, two approaches, and results: Thoracic duct cannulation in small laboratory animalsMicrosurgery, 2003